• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Qlucore

0.40 SEK

+17.15 %

Less than 1K followers

QCORE

First North Stockholm

IT Services

Technology

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+17.15 %
-10.44 %
-9.64 %
-19.08 %
-1.23 %
-14.69 %
-91.95 %
-
-98.56 %

Qlucore develops AI-based software for use in the healthcare sector. The company's precision medicine solutions transform genetic data into decision-making data to create the right treatment for patients. The company's first diagnostic test – for blood cancer in children – has been approved and CE-marked. The company also has tests for lung cancer under development, and is developing the Qlucore Omics Explorer analysis software.

Read more
Market cap
17.29M SEK
Turnover
32.05K SEK
Revenue
6.74M
EBIT %
-539.84 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Webcasts
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
9/9
2026

Interim report Q1'27

9/9
2026

General meeting '26

26/11
2026

Interim report Q2'27

Regulatory press release5/28/2026, 6:30 AM

Bokslutskommuniké 1 maj 2025 - 30 april 2026

Qlucore
Regulatory press release5/28/2026, 6:30 AM

Year-end-report 1 May 2025 - 30 April 2026

Qlucore
Press release4/20/2026, 12:00 PM

Qlucore lanserar AI-baserat test för blåscancer

Qlucore

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release4/20/2026, 12:00 PM

Qlucore Launches AI-based test for Bladder Cancer

Qlucore
Press release4/13/2026, 8:30 AM

Qlucore lanserar AI baserat test för akut myeloisk leukemi

Qlucore
Press release4/13/2026, 8:30 AM

Qlucore Launches AI-based test for Acute Myeloid Leukemia

Qlucore
Regulatory press release2/26/2026, 7:30 AM

Delårsrapport 1 maj 2025 - 31 januari 2026

Qlucore
Regulatory press release2/26/2026, 7:30 AM

Interim report 1 May 2025 - 31 January 2026

Qlucore
Press release2/23/2026, 4:10 PM

Inbjudan till presentation med frågestund av Qlucores delårsrapport för perioden 1 maj 2025 – 31 januari 2026

Qlucore
Press release2/23/2026, 4:10 PM

Invitation to presentation including Q&A session of Qlucore’s interim report for the period 1 May 2025 – 31 January 2026

Qlucore
Press release12/18/2025, 1:00 PM

Ny version av Qlucore Omics Explorer med förbättrat stöd för fördjupad analys av proteindata

Qlucore
Press release12/18/2025, 1:00 PM

New version of Qlucore Omics Explorer with enhanced support for in-depth proteomics analysis

Qlucore
Regulatory press release11/27/2025, 7:30 AM

Delårsrapport 1 maj - 31 oktober 2025

Qlucore
Regulatory press release11/27/2025, 7:30 AM

Interim report 1 May - 31 October 2025

Qlucore
Regulatory press release11/27/2025, 7:20 AM

Utrangering av immateriella tillgångar

Qlucore
Regulatory press release11/27/2025, 7:20 AM

Disposal of intangible assets

Qlucore
Press release11/25/2025, 10:00 AM

Invitation to presentation including Q&A session of Qlucore’s interim report for the period 1 May – 31 October 2025

Qlucore
Press release11/25/2025, 10:00 AM

Inbjudan till presentation med frågestund av Qlucores delårsrapport för perioden 1 maj – 31 oktober 2025

Qlucore
Regulatory press release10/28/2025, 8:30 AM

Qlucore terminates liquidity guarantee agreement

Qlucore
Regulatory press release10/28/2025, 8:30 AM

Qlucore avslutar avtal om likviditetsgaranti

Qlucore